MDAIHealthcare · Medical DevicesThe 1 Wall Street analysts covering Spectral AI, Inc. hold a median 12-month price target of $5.09 — +210.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 19 of 100 as at 8 Oct 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Spectral AI, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (81): Smaller than most of the companies we track.
Issuance (6): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on MDAI, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +210.4% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 27 May 2026 | BTIG | Maintains | Buy | $3.00 → $4.00 |
| 26 May 2026 | BTIG | Maintains | Buy | $3.00 → $4.00 |
| 25 Mar 2026 | BTIG | Reiterates | Buy | — |
| 10 Feb 2026 | BTIG | Reiterates | Buy | — |
| 12 Nov 2025 | BTIG | Maintains | Buy | — |
| 2 Apr 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 18 Mar 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 13 Aug 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 12 Aug 2024 | Northland Capital Markets | Initiates | Outperform | — |
| 18 July 2024 | HC Wainwright & Co. | Initiates | Buy | — |
| 23 Jan 2024 | BTIG | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MDAI appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 8 Oct 2026, Spectral AI, Inc. returned −35.2% against +16.2% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 26% of US stocks
Cheaper than 35% of US stocks
Cheaper than 97% of US stocks
Cheaper than 79% of US stocks
Higher than 9% of US stocks
Higher than 16% of US stocks
Higher than 36% of US stocks
Higher than 13% of US stocks
Higher than 8% of US stocks
Higher than 97% of US stocks
Higher than 10% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Spectral AI, Inc. has a market value of $52.8M and an enterprise value of $55.7M.
Revenue in the twelve months to 30 June 2026: $15.4M. The latest quarter shrank 30.4% year on year.
Net income over the same four quarters: −$10.1M, a −65.5% net margin.
Diluted earnings per share, trailing twelve months: $−0.35.
Free cash flow in the twelve months to 30 June 2026: −$12.9M.
Trailing P/E: 29.7×; forward P/E: −1.7× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Spectral AI, Inc. employs 65 people — $237K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Spectral AI, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Spectral AI announced that it submitted a New Technology Add-On Payment (NTAP) application to CMS for its DeepView™ System using the alternative pathway.
Why it matters — The application is a development related to potential Medicare payment for the DeepView System.
Spectral AI announced the completion of the first Site Initiation Visit for a clinical study supporting label expansion of its FDA-cleared DeepView System for Burn Indication to include burns of the head, hands, and feet. The visit was conducted at Pinderfields Hospital, Wakefield, UK, under Principal Investigator Dr. Preetha Muthayya.
Why it matters — This marks an early milestone in the company's effort to expand its commercial label for DeepView System, which could broaden the addressable patient population for its burn diagnostics.
Spectral AI, Inc. announced it will present at the ACS Clinical Congress 2026, taking place September 26-29, 2026 in Washington, DC, highlighting the use of artificial intelligence and multi-spectral imaging in the assessment of burn wounds. The presentation is scheduled at the upcoming conference.
Why it matters — A scheduled presentation at a major surgical congress provides Spectral AI with a platform to showcase its AI-based diagnostic technology for burn wound assessment to a professional medical audience.
Spectral AI, Inc. reflected on its successful participation at the Southern Regional Burn Conference (SRBC), held September 10-12, 2026 in Williamsburg, Virginia, where it showcased its DeepView System for burn indication and conducted key opinion leader research.
Why it matters — The conference participation highlights Spectral AI's engagement with the burn-care community and key opinion leaders, raising visibility for its DeepView diagnostics platform.
Spectral AI, Inc. (Nasdaq: MDAI) announced that CEO Vincent Capone and CFO David McGuire are scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference. The announcement was made by the company on September 1, 2026, via GlobeNewsWire.
Why it matters — A MDAI watcher would care because the company's leadership presenting at a major investment conference provides an opportunity to showcase its AI-driven wound-care diagnostics platform to investors and the broader financial community.
The 1 Wall Street analysts covering Spectral AI, Inc. have a median 12-month price target of $5.09, with estimates ranging from $4 to $6.25. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 1 analysts covering Spectral AI, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Spectral AI, Inc. 19 out of 100 across roughly 4,600 US stocks as at 8 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 8 Oct 2026, Spectral AI, Inc. ranks 19 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (81 of 100).
No one can know that. What the data says: the median 12-month target from 1 analysts implies +210.4% from the last close, and Ticker Nerd's factor model ranks Spectral AI, Inc. 19 out of 100 as at 8 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Spectral AI, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MDAI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $4 to $6.25 over the next 12 months.
Spectral AI, Inc. returned -35.2% over the 12 months to 8 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Spectral AI Inc. Class A Common Stock represents Spectral AI Inc., an artificial intelligence company focused on predictive medical diagnostics for wound care.
The most recent item we track (GlobeNewsWire, 6 Oct 2026): "Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ System". Spectral AI announced that it submitted a New Technology Add-On Payment (NTAP) application to CMS for its DeepView™ System using the alternative pathway.
Spectral AI Inc. Class A Common Stock represents Spectral AI Inc., an artificial intelligence company focused on predictive medical diagnostics for wound care. The company’s DeepView platform is designed to help clinicians assess wound healing potential before treatment by using proprietary AI and multispectral imaging to distinguish between damaged and healthy tissue. Its current work centers on supporting faster, more objective treatment decisions in burn care and diabetic foot ulcer applications, with additional clinical uses in development. Spectral AI serves the healthcare technology market by combining imaging, software, and diagnostic analysis into tools intended for physician use in hospital and clinical settings. Headquartered in Dallas, Texas, Spectral AI operates as a specialized medical technology business within the broader digital health and medical devices sector.
CEO Mr. Vincent Stanley Capone Esq. · 65 employees · United States · https://www.spectral-ai.com
